Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

BACKGROUND: In HIV infected patients, the impact of ribavirin (RBV) pharmacology on sustained virologic response (SVR) to hepatitis C virus (HCV) treatment has not been fully investigated. The objective of this study was to compare the early RBV plasma exposure between a population of HIV-HCV coinfe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatu, Giorgiana, Bailly, François, Pourcelot, Emmanuel, Pradat, Pierre, Miailhes, Patrick, Maynard, Marianne, Parant, François, Chiarello, Pierre, Livrozet, Jean-Michel, Zoulim, Fabien, Gagnieu, Marie-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994577/
https://www.ncbi.nlm.nih.gov/pubmed/24650094
http://dx.doi.org/10.1186/1471-2334-14-150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994577/
https://www.ncbi.nlm.nih.gov/pubmed/24650094
http://dx.doi.org/10.1186/1471-2334-14-150

Ejemplares similares